Grazyna Pinis

559 total citations
8 papers, 422 citations indexed

About

Grazyna Pinis is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Grazyna Pinis has authored 8 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 2 papers in Molecular Biology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Grazyna Pinis's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Signaling Pathways in Disease (2 papers) and Neuropeptides and Animal Physiology (2 papers). Grazyna Pinis is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Signaling Pathways in Disease (2 papers) and Neuropeptides and Animal Physiology (2 papers). Grazyna Pinis collaborates with scholars based in Poland, Sweden and United States. Grazyna Pinis's co-authors include A Szczeklik, Grażyna Bochenek, Maria Kumlin, Sven‐Erik Dahlén, O. Zetterström, Louise M. Dubé, Linda J. Swanson, Terry Boodhoo, Ewa Niżankowska and Barbro Dahlén and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal and Allergy.

In The Last Decade

Grazyna Pinis

8 papers receiving 400 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Grazyna Pinis Poland 4 350 219 109 105 56 8 422
Andrew R. Fischer United States 7 520 1.5× 314 1.4× 222 2.0× 142 1.4× 82 1.5× 7 643
J Rõzniecki Poland 9 240 0.7× 70 0.3× 128 1.2× 125 1.2× 66 1.2× 37 350
E Nizankowska Poland 7 513 1.5× 213 1.0× 456 4.2× 142 1.4× 35 0.6× 13 738
Pär Gyllfors Sweden 8 275 0.8× 124 0.6× 131 1.2× 87 0.8× 61 1.1× 11 358
Monika Świerczyńska Poland 5 328 0.9× 133 0.6× 354 3.2× 96 0.9× 17 0.3× 9 510
Jillian C. Bensko United States 9 304 0.9× 132 0.6× 184 1.7× 139 1.3× 43 0.8× 16 407
N Svanborg Sweden 9 250 0.7× 184 0.8× 106 1.0× 48 0.5× 19 0.3× 21 397
Ingrid Delin Sweden 8 304 0.9× 207 0.9× 82 0.8× 55 0.5× 89 1.6× 11 411
Esther Barrionuevo Spain 15 293 0.8× 67 0.3× 337 3.1× 341 3.2× 76 1.4× 27 607
S. Kundu United States 8 486 1.4× 428 2.0× 24 0.2× 133 1.3× 41 0.7× 20 576

Countries citing papers authored by Grazyna Pinis

Since Specialization
Citations

This map shows the geographic impact of Grazyna Pinis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Grazyna Pinis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Grazyna Pinis more than expected).

Fields of papers citing papers by Grazyna Pinis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Grazyna Pinis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Grazyna Pinis. The network helps show where Grazyna Pinis may publish in the future.

Co-authorship network of co-authors of Grazyna Pinis

This figure shows the co-authorship network connecting the top 25 collaborators of Grazyna Pinis. A scholar is included among the top collaborators of Grazyna Pinis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Grazyna Pinis. Grazyna Pinis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Kopiński, Piotr, J Szczeklik, Grazyna Pinis, et al.. (2010). [Modifications of the cytoimmunological pattern of bronchoalveolar lavage (BAL) material caused by cigarette smoking in selected lower air-way diseases].. PubMed. 67(10). 866–70. 1 indexed citations
2.
Kopiński, Piotr, Grzegorz Przybylski, Krzysztof Sładek, et al.. (2007). [Interferon gamma (IFN-gamma) level in broncholaveolar lavage (BAL) fluid is positively correlated with CD4/CD8 ratio in selected interstitial lung diseases].. PubMed. 23(133). 15–21. 3 indexed citations
3.
Kopiński, Piotr, et al.. (2007). [Cigarette smoking results in the number of CD8+Fas Ligand+ T cytotoxic lymphocytes in bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis (IPF)].. PubMed. 64(10). 689–94. 2 indexed citations
4.
Kopiński, Piotr, et al.. (2006). [Apoptosis of alveolar lymphocytes in sarcoidosis and in control group is more frequent in smokers than in nonsmoking persons].. PubMed. 63(10). 841–7. 2 indexed citations
5.
Dahlén, Barbro, Ewa Niżankowska, A Szczeklik, et al.. (1998). Benefits from Adding the 5-Lipoxygenase Inhibitor Zileuton to Conventional Therapy in Aspirin-intolerant Asthmatics. American Journal of Respiratory and Critical Care Medicine. 157(4). 1187–1194. 291 indexed citations
6.
Undas, Anetta & Grazyna Pinis. (1996). [Subclinical pro-thrombotic state in a relapse of Behcet's disease--case report].. PubMed. 96(3). 258–62. 1 indexed citations
7.
Nizankowska, E, Jerzy Soja, Grazyna Pinis, et al.. (1995). Treatment of steroid-dependent bronchial asthma with cyclosporin. European Respiratory Journal. 8(7). 1091–1099. 72 indexed citations
8.
Szczeklik, A, et al.. (1991). Cyclosporin for steroid‐dependent asthma. Allergy. 46(4). 312–315. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026